photonamic GmbH & Co. KG

MolecuLight specializes in innovative imaging solutions for wound care, particularly in the detection of harmful bacteria and the measurement of wounds. The company develops portable handheld optical imaging devices that allow medical practitioners to visualize bacteria and assess tissue viability at the point of care. These devices facilitate the documentation and monitoring of wound healing progress, enabling healthcare professionals to select the appropriate therapy for their patients in a timely manner. By providing accurate analysis and procedural guidance, MolecuLight's technology aims to enhance patient outcomes in wound management.

Upon conducting research with leaders in the field, it is clear that an ideal solution for neurosurgeons approaching removal of Glioblastoma is a procedure which: increases the precision and extent of tumor resection, has a manageable capital equipment cost for the hospital and has appropriate cost-benefit characteristics to the payers and does not introduce new medical risk factors - the use of Gliolan™ in conjunction with existing and growing installed base of fluorescence add-on kits manufactured by the two leading surgical microscope manufacturers provides just such a solution.